116 related articles for article (PubMed ID: 9575208)
1. Identification and characterization of a tannic acid-responsive negative regulatory element in the mouse mammary tumor virus promoter.
Uchiumi F; Sato T; Tanuma S
J Biol Chem; 1998 May; 273(20):12499-508. PubMed ID: 9575208
[TBL] [Abstract][Full Text] [Related]
2. Characterization of Smubp-2 as a mouse mammary tumor virus promoter-binding protein.
Uchiumi F; Komuro M; Mizuta R; Tanuma S
Biochem Biophys Res Commun; 2004 Aug; 321(2):355-63. PubMed ID: 15358184
[TBL] [Abstract][Full Text] [Related]
3. A redundant nuclear protein binding site contributes to negative regulation of the mouse mammary tumor virus long terminal repeat.
Bramblett D; Hsu CL; Lozano M; Earnest K; Fabritius C; Dudley J
J Virol; 1995 Dec; 69(12):7868-76. PubMed ID: 7494299
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of tannic acid on human immunodeficiency virus promoter activity induced by 12-O-tetra decanoylphorbol-13-acetate in Jurkat T-cells.
Uchiumi F; Maruta H; Inoue J; Yamamoto T; Tanuma S
Biochem Biophys Res Commun; 1996 Mar; 220(2):411-7. PubMed ID: 8645319
[TBL] [Abstract][Full Text] [Related]
5. Functional elements of the steroid hormone-responsive promoter of mouse mammary tumor virus.
Toohey MG; Lee JW; Huang M; Peterson DO
J Virol; 1990 Sep; 64(9):4477-88. PubMed ID: 2166825
[TBL] [Abstract][Full Text] [Related]
6. Cellular factors binding to a novel cis-acting element mediate steroid hormone responsiveness of mouse mammary tumor virus promoter.
Lee KI; Reddy EP; Reddy CD
J Biol Chem; 1995 Oct; 270(41):24502-8. PubMed ID: 7592667
[TBL] [Abstract][Full Text] [Related]
7. Role of the TATA box in transcription of the mouse mammary tumor virus long terminal repeat.
Kusk P; Carlson KE; Warren BS; Hager GL
Mol Endocrinol; 1995 Sep; 9(9):1180-92. PubMed ID: 7491110
[TBL] [Abstract][Full Text] [Related]
8. The long terminal repeat region of the mouse mammary tumour virus contains multiple regulatory elements.
Mink S; Ponta H; Cato AC
Nucleic Acids Res; 1990 Apr; 18(8):2017-24. PubMed ID: 2159634
[TBL] [Abstract][Full Text] [Related]
9. Cooperation between structural elements in hormono-regulated transcription from the mouse mammary tumor virus promoter.
Gouilleux F; Sola B; Couette B; Richard-Foy H
Nucleic Acids Res; 1991 Apr; 19(7):1563-9. PubMed ID: 1851294
[TBL] [Abstract][Full Text] [Related]
10. CDP binding to multiple sites in the mouse mammary tumor virus long terminal repeat suppresses basal and glucocorticoid-induced transcription.
Zhu Q; Dudley JP
J Virol; 2002 Mar; 76(5):2168-79. PubMed ID: 11836394
[TBL] [Abstract][Full Text] [Related]
11. Trans-retinoic acid and glucocorticoids synergistically induce transcription from the mouse mammary tumor virus promoter in human embryonic kidney cells.
Medh RD; Schmidt TJ
J Steroid Biochem Mol Biol; 1997 Jun; 62(2-3):129-42. PubMed ID: 9393948
[TBL] [Abstract][Full Text] [Related]
12. Mouse mammary tumor virus gene expression is suppressed by oligomeric ellagitannins, novel inhibitors of poly(ADP-ribose) glycohydrolase.
Tsai YJ; Aoki T; Maruta H; Abe H; Sakagami H; Hatano T; Okuda T; Tanuma S
J Biol Chem; 1992 Jul; 267(20):14436-42. PubMed ID: 1321148
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of a cis-acting element that interferes with glucocorticoid-inducible activation of the mouse mammary tumor virus promoter.
Tanaka H; Dong Y; Li Q; Okret S; Gustafsson JA
Proc Natl Acad Sci U S A; 1991 Jun; 88(12):5393-7. PubMed ID: 1647031
[TBL] [Abstract][Full Text] [Related]
14. A macrocircular ellagitannin, oenothein B, suppresses mouse mammary tumor gene expression via inhibition of poly(ADP-ribose) glycohydrolase.
Aoki K; Maruta H; Uchiumi F; Hatano T; Yoshida T; Tanuma S
Biochem Biophys Res Commun; 1995 May; 210(2):329-37. PubMed ID: 7755607
[TBL] [Abstract][Full Text] [Related]
15. Mouse mammary tumor virus proviruses in T-cell lymphomas lack a negative regulatory element in the long terminal repeat.
Hsu CL; Fabritius C; Dudley J
J Virol; 1988 Dec; 62(12):4644-52. PubMed ID: 2846876
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel dexamethasone responsive enhancer in the human CYP3A5 gene and its activation in human and rat liver cells.
Schuetz JD; Schuetz EG; Thottassery JV; Guzelian PS; Strom S; Sun D
Mol Pharmacol; 1996 Jan; 49(1):63-72. PubMed ID: 8569713
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoid and progestin receptors are differently involved in the cooperation with a structural element of the mouse mammary tumor virus promoter.
Le Ricousse S; Gouilleux F; Fortin D; Joulin V; Richard-Foy H
Proc Natl Acad Sci U S A; 1996 May; 93(10):5072-7. PubMed ID: 8643531
[TBL] [Abstract][Full Text] [Related]
18. Two regions of the mouse mammary tumor virus long terminal repeat regulate the activity of its promoter in mammary cell lines.
Lefebvre P; Berard DS; Cordingley MG; Hager GL
Mol Cell Biol; 1991 May; 11(5):2529-37. PubMed ID: 1708094
[TBL] [Abstract][Full Text] [Related]
19. NF-kappa B site-mediated negative regulation of the HIV-1 promoter by CCAAT/enhancer binding proteins in brain-derived cells.
Mondal D; Alam J; Prakash O
J Mol Neurosci; 1994-1995; 5(4):241-58. PubMed ID: 7577367
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a corticotropin-releasing hormone-responsive element in the rat proopiomelanocortin gene promoter and molecular cloning of its binding protein.
Jin WD; Boutillier AL; Glucksman MJ; Salton SR; Loeffler JP; Roberts JL
Mol Endocrinol; 1994 Oct; 8(10):1377-88. PubMed ID: 7854355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
